Oppenheimer, BMO, Merriman, Needham Downgrade Poinard (PARD) Following Negative Picoplatin Data Nov 16, 2009 11:40AM
Notable Analyst Rating Changes 11/16: COH, JWN, GNK, ESEA, SVA, YGE Upgraded; PARD, GPS, JCP, DLTR Downgraded Nov 16, 2009 11:10AM
BMO Capital Initiates Coverage on Poniard Pharmaceuticals (PARD) with a Speculative Outperform Oct 6, 2009 08:09AM